Sotalol and mexiletine

Combination of rate-dependent electrophysiological effects

A. Varró, David A. Lathrop

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

The rate-dependent electrophysiological effects of sotalol (30 μM), mexiletine (10 and 18 μM), and their coadministration were examined in isolated dog cardiac Purkinje fibers following abrupt changes in pacing cycle length. Combination of 30 μM sotalol with 10 μM mexiletine significantly lengthened premature action potential durations at diastolic intervals of <50 ms while the basic action potential duration evoked at a stimulus frequency of 2 Hz was not affected. This effect on the premature action potential duration was attenuated when the higher mexiletine concentration (18 μM) was coadministered with sotalol. The fast time constant for restitution of the action potential duration was significantly slowed by either combination. Coadministration of sotalol and mexiletine, like mexiletine alone, produced a rate-dependent depression of ±max that displayed a second slow time component during recovery. This slow component for recovery of ±max was not distinguished in the absence of drug or in the presence of sotalol alone. Sotalol-induced lengthening of the action potential duration observed at slow pacing frequencies was also attenuated by addition of mexiletine; and, under these conditions, Purkinje fiber early afterdepolarizations were prevented. In addition, the range of premature action potential durations was significantly decreased by mexiletine and by the combination, while sotalol alone increased this range slightly. These results indicate that coadministration of sotalol and mexiletine may provide beneficial electrophysiological effects expected to provide enhanced antiarrhythmic efficacy and fewer proarrhythmic complications in patients.

Original languageEnglish
Pages (from-to)557-567
Number of pages11
JournalJournal of Cardiovascular Pharmacology
Volume16
Issue number4
Publication statusPublished - 1990

Fingerprint

Mexiletine
Sotalol
Action Potentials
Purkinje Fibers
Dogs

Keywords

  • Action potential duration
  • Combination drug therapy
  • Mexiletine
  • Purkinje fibers
  • Rate-dependent effects
  • Sotalol

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Pharmacology

Cite this

Sotalol and mexiletine : Combination of rate-dependent electrophysiological effects. / Varró, A.; Lathrop, David A.

In: Journal of Cardiovascular Pharmacology, Vol. 16, No. 4, 1990, p. 557-567.

Research output: Contribution to journalArticle

@article{d02d46e3a9304d07bb71ea07590d8143,
title = "Sotalol and mexiletine: Combination of rate-dependent electrophysiological effects",
abstract = "The rate-dependent electrophysiological effects of sotalol (30 μM), mexiletine (10 and 18 μM), and their coadministration were examined in isolated dog cardiac Purkinje fibers following abrupt changes in pacing cycle length. Combination of 30 μM sotalol with 10 μM mexiletine significantly lengthened premature action potential durations at diastolic intervals of <50 ms while the basic action potential duration evoked at a stimulus frequency of 2 Hz was not affected. This effect on the premature action potential duration was attenuated when the higher mexiletine concentration (18 μM) was coadministered with sotalol. The fast time constant for restitution of the action potential duration was significantly slowed by either combination. Coadministration of sotalol and mexiletine, like mexiletine alone, produced a rate-dependent depression of ±max that displayed a second slow time component during recovery. This slow component for recovery of ±max was not distinguished in the absence of drug or in the presence of sotalol alone. Sotalol-induced lengthening of the action potential duration observed at slow pacing frequencies was also attenuated by addition of mexiletine; and, under these conditions, Purkinje fiber early afterdepolarizations were prevented. In addition, the range of premature action potential durations was significantly decreased by mexiletine and by the combination, while sotalol alone increased this range slightly. These results indicate that coadministration of sotalol and mexiletine may provide beneficial electrophysiological effects expected to provide enhanced antiarrhythmic efficacy and fewer proarrhythmic complications in patients.",
keywords = "Action potential duration, Combination drug therapy, Mexiletine, Purkinje fibers, Rate-dependent effects, Sotalol",
author = "A. Varr{\'o} and Lathrop, {David A.}",
year = "1990",
language = "English",
volume = "16",
pages = "557--567",
journal = "Journal of Cardiovascular Pharmacology",
issn = "0160-2446",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Sotalol and mexiletine

T2 - Combination of rate-dependent electrophysiological effects

AU - Varró, A.

AU - Lathrop, David A.

PY - 1990

Y1 - 1990

N2 - The rate-dependent electrophysiological effects of sotalol (30 μM), mexiletine (10 and 18 μM), and their coadministration were examined in isolated dog cardiac Purkinje fibers following abrupt changes in pacing cycle length. Combination of 30 μM sotalol with 10 μM mexiletine significantly lengthened premature action potential durations at diastolic intervals of <50 ms while the basic action potential duration evoked at a stimulus frequency of 2 Hz was not affected. This effect on the premature action potential duration was attenuated when the higher mexiletine concentration (18 μM) was coadministered with sotalol. The fast time constant for restitution of the action potential duration was significantly slowed by either combination. Coadministration of sotalol and mexiletine, like mexiletine alone, produced a rate-dependent depression of ±max that displayed a second slow time component during recovery. This slow component for recovery of ±max was not distinguished in the absence of drug or in the presence of sotalol alone. Sotalol-induced lengthening of the action potential duration observed at slow pacing frequencies was also attenuated by addition of mexiletine; and, under these conditions, Purkinje fiber early afterdepolarizations were prevented. In addition, the range of premature action potential durations was significantly decreased by mexiletine and by the combination, while sotalol alone increased this range slightly. These results indicate that coadministration of sotalol and mexiletine may provide beneficial electrophysiological effects expected to provide enhanced antiarrhythmic efficacy and fewer proarrhythmic complications in patients.

AB - The rate-dependent electrophysiological effects of sotalol (30 μM), mexiletine (10 and 18 μM), and their coadministration were examined in isolated dog cardiac Purkinje fibers following abrupt changes in pacing cycle length. Combination of 30 μM sotalol with 10 μM mexiletine significantly lengthened premature action potential durations at diastolic intervals of <50 ms while the basic action potential duration evoked at a stimulus frequency of 2 Hz was not affected. This effect on the premature action potential duration was attenuated when the higher mexiletine concentration (18 μM) was coadministered with sotalol. The fast time constant for restitution of the action potential duration was significantly slowed by either combination. Coadministration of sotalol and mexiletine, like mexiletine alone, produced a rate-dependent depression of ±max that displayed a second slow time component during recovery. This slow component for recovery of ±max was not distinguished in the absence of drug or in the presence of sotalol alone. Sotalol-induced lengthening of the action potential duration observed at slow pacing frequencies was also attenuated by addition of mexiletine; and, under these conditions, Purkinje fiber early afterdepolarizations were prevented. In addition, the range of premature action potential durations was significantly decreased by mexiletine and by the combination, while sotalol alone increased this range slightly. These results indicate that coadministration of sotalol and mexiletine may provide beneficial electrophysiological effects expected to provide enhanced antiarrhythmic efficacy and fewer proarrhythmic complications in patients.

KW - Action potential duration

KW - Combination drug therapy

KW - Mexiletine

KW - Purkinje fibers

KW - Rate-dependent effects

KW - Sotalol

UR - http://www.scopus.com/inward/record.url?scp=0025072293&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025072293&partnerID=8YFLogxK

M3 - Article

VL - 16

SP - 557

EP - 567

JO - Journal of Cardiovascular Pharmacology

JF - Journal of Cardiovascular Pharmacology

SN - 0160-2446

IS - 4

ER -